| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |